Arun J Sanyal1, Prakash Jha2, David E Kleiner3

  • 1Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. arun.sanyal@vcuhealth.org.

概括

对非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 的组织学评估面临挑战. 机器学习和数字工具为评估药物疗效和临床评估提供了有前途的进展.